title: Male osteoporosis: who should be treated and how?
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Biver
authors.forename: Séverine
authors.initials: S
authors.lastname: Borg
authors.forename: Florence
authors.initials: F
authors.lastname: Chopin
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Hoppé
authors.forename: Gauthier
authors.initials: G
authors.lastname: Morel
authors.forename: Bernard
authors.initials: B
authors.lastname: Cortet
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001862:Bone Resorption / Q000188:drug therapy; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D058866:Osteoporotic Fractures / Q000517:prevention & control*; D018579:Patient Selection; D011159:Population Surveillance; D012307:Risk Factors
chemical_list: D050071:Bone Density Conservation Agents